Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Warning:

This online archive of the CDC Prevention Guidelines Database is being maintained for historical purposes, and has had no new entries since October 1998. To find more recent guidelines, please visit the following:


Prevention Guidelines

Topic: AIDS

(Please note that the documents listed below are sorted by date.)

Management of Possible Sexual, Injecting-Drug-Use, or Other Nonoccupational Exposure to HIV, Including Considerations Related to Antiretroviral Therapy Public Health Service Statement; 1998:09:25

HIV Prevention Through Early Detection and Treatment of Other Sexually Transmitted Diseases -- United States Recommendations of the Advisory Committee for HIV and STD Prevention; 1998:07:31

Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis; 1998:05:15

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents; 1998:04:24

Report of the NIH Panel to Define Principles of Therapy of HIV Infection; 1998:04:24

Update: HIV Counseling and Testing Using Rapid Tests -- United States, 1995; 1998:03:27

Administration of Zidovudine During Late Pregnancy and Delivery to Prevent Perinatal HIV Transmission -- Thailand, 1996-1998; 1998:03:06

HIV/AIDS Among American Indians and Alaskan Natives -- United States, 1981-1997; 1998:03:06

1998 Guidelines for Treatment of Sexually Transmitted Diseases; 1998:01:23

Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations; 1997:09:05

1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus; 1997:06:27

Update: Syringe-Exchange Programs -- United States, 1996; 1997:06:20

Notice to Readers Publication of HIV-Prevention Bulletin for Health-Care Providers Regarding Advice to Persons Who Inject Illicit Drugs; 1997:06:06

Case Definitions for Infectious Conditions Under Public Health Surveillance; 1997:05:02

1997 Revised Guidelines for Performing CD4+ T-Cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV); 1997:01:10

Coccidioidomycosis -- Arizona, 1990-1995; 1996:12:13

Health Information for International Travel 1996-97; 1996:12:01

Notice to Readers Update: Provisional Public Health Service Recommendations For Chemoprophylaxis After Occupational Exposure to HIV; 1996:06:07

Community-Level Prevention of Human Immunodeficiency Virus Infection Among High-Risk Populations: The AIDS Community Demonstration Projects; 1996:05:10

Guidelines for Isolation Precautions in Hospitals Hospital Infection Control Advisory Committee; 1996:01:01

Case-Control Study of HIV Seroconversion in Health-Care Workers After Percutaneous Exposure to HIV-Infected Blood -- France, United Kingdom, and United States, January 1988-August 1994; 1995:12:22

Essential Components of a Tuberculosis Prevention and Control Program Recommendations of the Advisory Council for the Elimination of Tuberculosis; 1995:09:08

Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations Recommendations of the Advisory Council for the Elimination of Tuberculosis; 1995:09:08

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: A Summary; 1995:07:14

U.S. Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women; 1995:07:07

Assessing the Public Health Threat Associated with Waterborne Cryptosporidiosis: Report of a Workshop; 1995:06:16

1995 Revised Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with or Perinatally Exposed to Human Immunodeficiency Virus; 1995:04:28

Guidelines for Health Education and Risk Reduction Activities; 1995:04:01

1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age; 1994:09:30

Official Authorized Addenda: Human Immunodeficiency Virus Infection Codes and Official Guidelines for Coding and Reporting ICD-9-CM; 1994:09:30

Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus; 1994:08:05

Guidelines for Preventing Transmission of Human Immunodeficiency Virus Through Transplantation of Human Tissue and Organs; 1994:05:20

Zidovudine for the Prevention of HIV Transmission from Mother to Infant; 1994:04:29

Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States Executive Summary; 1994:04:15

Update: Barrier Protection Against HIV Infection and Other Sexually Transmitted Diseases; 1993:08:06

Acquired Immunodeficiency Syndrome -- United States, 1992; 1993:07:23

Recommendations for Counseling Persons Infected with Human T-Lymphotrophic Virus, Types I and II *; 1993:06:25

Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex for Adults and Adolescents Infected with Human Immunodeficiency Virus; 1993:06:25

Investigations of Persons Treated by HIV-Infected Health-Care Workers -- United States; 1993:05:07

Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence; 1993:04:09

Recommendations for HIV Testing Services for Inpatients and Outpatients in Acute-Care Hospital Settings; 1993:01:15

Technical Guidance on HIV Counseling; 1993:01:15

Dental Infection Control File, 1993 and Recommended Infection- Control Practices for Dentistry, 1993; 1993:01:01

1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults; 1992:12:18

CDC/ATSDR Protocol for Handling Occupational Exposures to Human Immunodeficiency Virus (HIV); 1992:11:10

Patient Exposures to HIV During Nuclear Medicine Procedures; 1992:08:07

Testing for Antibodies to Human Immunodeficiency Virus Type 2 in the United States; 1992:07:17

Management of Persons Exposed to Multidrug-Resistant Tuberculosis; 1992:06:19

National Action Plan to Combat Multidrug-Resistant Tuberculosis; 1992:06:19

Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection; 1992:05:08

Recommendations for Prophylaxis Against Pneumocystis carinii Pneumonia for Adults and Adolescents Infected with Human Immunodeficiency Virus; 1992:04:03

Interpretive Criteria Used to Report Western Blot Results for HIV-1-Antibody Testing -- United States; 1991:10:11

Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures; 1991:07:12

Epidemiologic Notes and Reports Update: Transmission of HIV Infection During Invasive Dental Procedures --- Florida; 1991:06:14

Current Trends Preliminary Analysis: HIV Serosurvey of Orthopedic Surgeons, 1991; 1991:05:17

Purified Protein Derivative (PPD)-Tuberculin Anergy and HIV Infection: Guidelines For Anergy Testing And Management Of Anergic Persons At Risk Of Tuberculosis; 1991:04:26

Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus; 1991:03:15

Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus; 1991:03:15

Epidemiologic Notes and Reports Update: Transmission of HIV Infection during an Invasive Dental Procedure -- Florida; 1991:01:18

Epidemiologic Notes and Reports Risk for Cervical Disease in HIV-Infected Women -- New York City; 1990:11:30

Current Trends Surveillance for HIV-2 Infection in Blood Donors -- United States, 1987-1989; 1990:11:23

Epidemiologic Notes and Reports Nosocomial Transmission of Multidrug-Resistant Tuberculosis to Health-Care Workers and HIV-Infected Patients in an Urban Hospital -- Florida; 1990:10:12

International Notes Tuberculin Reactions in Apparently Healthy HIV-Seropositive and HIV-Seronegative Women -- Uganda; 1990:09:21

Possible Transmission of Human Immunodeficiency Virus to a Patient during an Invasive Dental Procedure; 1990:07:27

Epidemiologic Notes and Reports HIV-1 Infection and Artificial Insemination with Processed Semen; 1990:04:20

Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use; 1990:01:26

HIV Infection Reporting -- United States; 1989:07:21

Interpretation and Use of the Western Blot Assay for Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections; 1989:07:21

Current Trends Update: Heterosexual Transmission of Acquired Immunodeficiency Syndrome and Human Immunodeficiency Virus Infection -- United States; 1989:06:23

Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public-Safety Workers; 1989:06:23

Current Trends Problems Created by Heat-Inactivation of Serum Specimens Before HIV-1 Antibody Testing; 1989:06:16

Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Persons Infected with Human Immunodeficiency Virus; 1989:06:16

Perspectives in Disease Prevention and Health Promotion Guidelines to Prevent Simian Immunodeficiency Virus Infection in Laboratory Workers and Animal Handlers; 1988:11:18

Epidemiologic Notes and Reports Transmission of HIV Through Bone Transplantation: Case Report and Public Health Recommendations; 1988:10:07

Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome Revised Chapter X from "Guidelines for STD Control Program Operations"; 1988:09:01

Current Trends Partner Notification for Preventing Human Immunodeficiency Virus (HIV) Infection -- Colorado, Idaho, South Carolina, Virginia; 1988:07:01

Perspectives in Disease Prevention and Health Promotion Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus, and Other Bloodborne Pathogens ; 1988:06:24

Update: Acquired Immunodeficiency Syndrome and Human Immunodefiency Virus Infection Among Health-Care Workers; 1988:04:22

Agent Summary Statement for Human Immunodeficiency Viruses (HIVs) Including HTLV-III, LAV, HIV-1, and HIV-2*; 1988:04:01

Occupationally Acquired Human Immunodeficiency Virus Infections in Laboratories Producing Virus Concentrates in Large Quantities: Conclusions and Recommendations of an Expert Team Convened by the Dire; 1988:04:01

Recommendations of the Immunization Practices Advisory Committee (ACIP) Immunization of Children Infected With Human Immunodeficiency Virus --; 1988:04:01

Perspectives in Disease Prevention and Health Promotion Semen Banking, Organ and Tissue Transplantation, and HIV Antibody Testing; 1988:02:05

Guidelines for Effective School Health Education To Prevent the Spread of AIDS; 1988:01:29

Guidelines for the Prevention and Control of Congenital Syphilis; 1988:01:15

Current Trends Update: Serologic Testing for Antibody to Human Immunodeficiency Virus; 1988:01:08

Notice to Readers Revision of HIV Classification Codes; 1988:01:01

Guidelines for AIDS Prevention Program Operations; 1987:10:01

Recommendations for Prevention of HIV Transmission in Health-Care Settings; 1987:08:21

Perspectives in Disease Prevention and Health Promotion Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV Infection and AIDS; 1987:08:14

Epidemiologic Notes and Reports Human Immunodeficiency Virus Infection Transmitted From on Organ Donor Screened for HIV Antibody - North Carolina; 1987:05:29

Epidemiologic Notes and Reports Update: Human Immunodeficiency Virus Infections in Health-Care Workers Exposed to Blood of Infected Patients; 1987:05:22

Current Trends Classification System for Human Immunodeficiency Viru (HIV) Infection in Children Under 13 Years of Age; 1987:04:24

Recommendation of the Immunization Practices Advisory Committee Immunization of Children Infected with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1986:09:26

Tuberculosis and Acquired Immunodeficiency Syndrome -- Florida; 1986:09:19

Current Trends Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus: Agent Summary Statement; 1986:08:29

Diagnosis and Management of Mycobacterial Infection and Disease in Persons with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection; 1986:07:18

Current Trends Recommendations for Providing Dialysis Treatment to Patients Infected with Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus; 1986:06:13

Current Trends Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus during Invasive Procedures; 1986:04:11

Safety of Therapeutic Immune Globulin Preparations with Respect to Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection; 1986:04:11

Current Trends Additional Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1986:03:14

Current Trends Recommendations for Assisting in the Prevention of Perinatal Transmission of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Acquired Immunodeficiency Syndrome; 1985:12:06

Current Trends Summary: Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15

Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15

Epidemiologic Notes and Reports Update: Evaluation of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection in Health-Care Personnel -- United States; 1985:09:27

Update: Revised Public Health Service Definition of Persons Who Should Refrain from Donating Blood and Plasma -- United States; 1985:09:06

Current Trends Education and Foster Care of Children Infected with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1985:08:30

Current Trends Recommendations for Preventing Possible Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy- Associated Virus from Tears; 1985:08:30

Epidemiologic Notes and Reports Testing Donors of Organs, Tissues, and Semen for Antibody to Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus; 1985:05:24

Current Trends World Health Organization Workshop: Conclusions and Recommendations on Acquired Immunodeficiency Syndrome; 1985:05:17

Current Trends Update: Prospective Evaluation of Health-Care Workers Exposed via the Parenteral or Mucous-Membrane Route to Blood or Body Fluids from Patients with Acquired Immunodeficiency Syndrome -; 1985:02:22

Provisional Public Health Service Inter-Agency Recommendations for Screening Donated Blood and Plasma for Antibody to the Virus Causing Acquired Immunodeficiency Syndrome; 1985:01:11

Current Trends Hepatitis B Vaccine: Evidence Confirming Lack of AIDS Transmission; 1984:12:14

Update: Acquired Immunodeficiency Syndrome (AIDS) in Persons with Hemophilia; 1984:10:26

Prospective Evaluation of Health-Care Workers Exposed via Parenteral or Mucous-Membrane Routes to Blood and Body Fluids of Patients with Acquired Immunodeficiency Syndrome; 1984:04:06

Acquired Immunodeficiency Syndrome (AIDS): Precautions for Health-Care Workers and Allied Professionals; 1983:09:02

Epidemiologic Notes and Reports An Evaluation of the Acquired Immunodeficiency Syndrome (AIDS) Reported in Health-Care Personnel -- United States; 1983:07:15

Current Trends Prevention of Acquired Immune Deficiency Syndrome (AIDS): Report of Inter-Agency Recommendations; 1983:03:04

Current Trends Acquired Immune Deficiency Syndrome (AIDS): Precautions for Clinical and Laboratory Staffs; 1982:11:05




This page last reviewed: Wednesday, January 27, 2016
TOP